Free Trial

Anthem (NASDAQ:ANTX) Upgraded by Wall Street Zen to "Hold" Rating

Anthem logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Wall Street Zen upgraded Anthem (NASDAQ:ANTX) to a "Hold" while Weiss Ratings initiated coverage with a "Sell (D-)," leaving a MarketBeat consensus rating of Hold and a consensus price target of $2.00.
  • ANTX opened at $2.97, has a 52‑week range of $1.00–$6.91 and a market cap of $106.74 million, and reported negative earnings (latest EPS −$0.29) with analysts forecasting about −1.7 EPS for the year, signaling weak fundamentals.
  • Interested in Anthem? Here are five stocks we like better.

Anthem (NASDAQ:ANTX - Get Free Report) was upgraded by stock analysts at Wall Street Zen to a "hold" rating in a research note issued to investors on Saturday.

Separately, Weiss Ratings assumed coverage on Anthem in a report on Tuesday. They set a "sell (d-)" rating on the stock. One equities research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $2.00.

Get Our Latest Stock Analysis on Anthem

Anthem Stock Performance

Shares of ANTX stock opened at $2.97 on Friday. Anthem has a fifty-two week low of $1.00 and a fifty-two week high of $6.91. The stock's fifty day moving average is $2.59 and its two-hundred day moving average is $1.67. The firm has a market capitalization of $106.74 million, a P/E ratio of -2.56 and a beta of -1.31.

Anthem (NASDAQ:ANTX - Get Free Report) last released its earnings results on Tuesday, March 17th. The company reported ($0.29) earnings per share (EPS) for the quarter. On average, equities analysts forecast that Anthem will post -1.7 earnings per share for the current year.

About Anthem

(Get Free Report)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anthem Right Now?

Before you consider Anthem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anthem wasn't on the list.

While Anthem currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines